200 related articles for article (PubMed ID: 31701679)
21. Primary Central Nervous System Tumors: Comparing Two National Cancer Registries.
Yolcu Y; Wahood W; Kerezoudis P; Alvi MA; Habermann EB; Bydon M
World Neurosurg; 2019 Aug; 128():e719-e731. PubMed ID: 31077903
[TBL] [Abstract][Full Text] [Related]
22. Adult leukemia survival trends in the United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009.
Bailey C; Richardson LC; Allemani C; Bonaventure A; Harewood R; Moore AR; Stewart SL; Weir HK; Coleman MP;
Cancer; 2018 Oct; 124(19):3856-3867. PubMed ID: 30343495
[TBL] [Abstract][Full Text] [Related]
23. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
Pan Y; Lu L; Chen J; Zhong Y; Dai Z
J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
[TBL] [Abstract][Full Text] [Related]
24. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
[TBL] [Abstract][Full Text] [Related]
25. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma.
Fiala MA; Finney JD; Liu J; Stockerl-Goldstein KE; Tomasson MH; Vij R; Wildes TM
Leuk Lymphoma; 2015; 56(9):2643-9. PubMed ID: 25651424
[TBL] [Abstract][Full Text] [Related]
26. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological trends in uveal melanoma.
Andreoli MT; Mieler WF; Leiderman YI
Br J Ophthalmol; 2015 Nov; 99(11):1550-3. PubMed ID: 25904122
[TBL] [Abstract][Full Text] [Related]
28. Implications of missing data on reported breast cancer mortality.
Plichta JK; Rushing CN; Lewis HC; Rooney MM; Blazer DG; Thomas SM; Hwang ES; Greenup RA
Breast Cancer Res Treat; 2023 Jan; 197(1):177-187. PubMed ID: 36334190
[TBL] [Abstract][Full Text] [Related]
29. Case-Completeness of Nonmalignant Central Nervous System Tumors in the Canadian Cancer Registry, 2011-2015.
Zakaria D; Shaw A; Woods R; De P; Davis F
J Registry Manag; 2018; 45(1):117-131. PubMed ID: 31017881
[TBL] [Abstract][Full Text] [Related]
30. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States.
Sirri E; Castro FA; Kieschke J; Jansen L; Emrich K; Gondos A; Holleczek B; Katalinic A; Urbschat I; Vohmann C; Brenner H
Pancreas; 2016 Jul; 45(6):908-14. PubMed ID: 26745860
[TBL] [Abstract][Full Text] [Related]
31. Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry.
Ho PJ; Moore EM; McQuilten ZK; Wellard C; Bergin K; Augustson B; Blacklock H; Harrison SJ; Horvath N; King T; Mollee P; Quach H; Reid C; Rosengarten B; Walker P; Wood EM; Spencer A
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e415-e424. PubMed ID: 31208889
[TBL] [Abstract][Full Text] [Related]
32. Contemporary survival trends in penile cancer: Results from the National Cancer Database.
Pham MN; Deal AM; Ferguson JE; Wang Y; Smith AB; Nielsen ME; Pruthi RS; Woods ME
Urol Oncol; 2017 Dec; 35(12):674.e1-674.e9. PubMed ID: 28882672
[TBL] [Abstract][Full Text] [Related]
33. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
34. A registry-based analysis of survival outcomes in mast cell leukemia.
Budnik J; Milano MT
Leuk Res; 2019 Mar; 78():24-28. PubMed ID: 30665051
[TBL] [Abstract][Full Text] [Related]
35. Overall Survival Trends and Clinical Characteristics of Plasmacytoma in the United States: A National Cancer Database Analysis.
Ghiassi-Nejad Z; Ru M; Moshier E; Chang S; Jagannath S; Dharmarajan K
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):310-319. PubMed ID: 30878315
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
37. Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012-2014.
Mallin K; Browner A; Palis B; Gay G; McCabe R; Nogueira L; Yabroff R; Shulman L; Facktor M; Winchester DP; Nelson H
Ann Surg Oncol; 2019 Jun; 26(6):1604-1612. PubMed ID: 30737668
[TBL] [Abstract][Full Text] [Related]
38. Comparison of cases captured in the national cancer data base with those in population-based central cancer registries.
Lerro CC; Robbins AS; Phillips JL; Stewart AK
Ann Surg Oncol; 2013 Jun; 20(6):1759-65. PubMed ID: 23475400
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
40. Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying).
Ostrom QT; Gittleman H; Kruchko C; Louis DN; Brat DJ; Gilbert MR; Petkov VI; Barnholtz-Sloan JS
J Neurooncol; 2016 Oct; 130(1):31-42. PubMed ID: 27418206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
